Valeant Pharmaceuticals Buys Obagi Medical For $360M
socalTECH
MARCH 20, 2013
Long Beach-based Obagi Medical Products , the developer of aesthetic medicine products, is being acquired by Valeant Pharmaceuticals , in a deal worth approximately $360M, Obagi said this morning. per share in cash, a 42 percent premium to Obagi's closing share price on Thursday, March 14th. READ MORE>>.
Let's personalize your content